U.S. Markets open in 8 hrs 20 mins

The Zacks Analyst Blog Highlights: Microsoft, Royal Dutch, IBM, Thermo Fisher and American Tower

Zacks Equity Research

For Immediate Release

Chicago, IL –October 10, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft MSFT, Royal Dutch Shell RDS.A, IBM IBM, Thermo Fisher Scientific TMO and American Tower AMT.

Here are highlights from Wednesday’s Analyst Blog:

Top Stock Reports for Microsoft, Royal Dutch Shell and IBM

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft, Royal Dutch Shell and IBM. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Microsoft’s shares have outperformed the S&P 500 year to date (33.6% vs. 15.3%). The Zacks analyst believes that Microsoft is benefiting from growing user base of its different applications like Office 365 commercial, Dynamics, Outlook mobile and Teams.

Moreover, Azure’s expanding customer base is a key catalyst. Microsoft’s gaming segment is performing well, primarily driven by a combination of Xbox Live, Game Pass subscriptions and Mixer, which are driving user engagement. Further, acquisitions like PlayFab and GitHub expand Microsoft’s total addressable market and penetration. Additionally, an expanding partner base is notable.

However, projections of a moderating growth rate in commercial cloud gross margin, and OEM Pro and Windows commercial businesses is a headwind. Moreover, competition from the likes of Google, Apple, Sony and Nintendo is intense.

(You can read the full research report on Microsoft here >>>)

Shares of Royal Dutch Shell have lost 13.2% in the past six months, outperforming the Zacks International Integrated Oil industry’s fall of 16.7%. The Zacks analyst states that company’s cash flow continues to increase, allowing it to cut debt while covering the share buybacks and cash dividend.

As it is, the Anglo-Dutch company's position as a key supplier of liquefied natural gas should drive long-term cash flow growth on attractive opportunities. However, there are worries over a drop in its downstream segment earnings while the company’s poor reserve replacement ratio raises concerns about future production.

Shell's operations in violence-prone regions of Nigeria pose additional risk. Hence, investors are advised to wait for a better entry point.

(You can read the full research report on Royal Dutch here >>>).

IBM’s shares have lost 1.5% over the past three months compared with the S&P 500’s decline of 2.9%. The Zacks analyst believes that IBM is benefiting from operating efficiency, cost cutting and lower share count.

Moreover, the company’s improving position in the hosted cloud, security and analytics holds promise. The company is also witnessing growth in industry verticals like health as well as key areas of analytics and security. Solid adoption of Watson Health and broad-based growth in Payer, Provider, Imaging and Life Sciences domains, is also noteworthy.

The RedHat acquisition aimed at improving hybrid cloud platform is likely to enhance IBM's prospects. Notably, the company has a positive record of earnings surprises in recent quarters.

However, softness in cognitive solutions and technology & cloud platforms remains a concern. Competition for the Storage hardware segment is stiff. A highly leveraged balance sheet adds to the woes.

 (You can read the full research report on IBM here >>>).

Other noteworthy reports we are featuring today include Thermo Fisher Scientific and American Tower.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339



Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
International Business Machines Corporation (IBM) : Free Stock Analysis Report
American Tower Corporation (REIT) (AMT) : Free Stock Analysis Report
Microsoft Corporation (MSFT) : Free Stock Analysis Report
Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report
Royal Dutch Shell PLC (RDS.A) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research